勘误：用于心律失常风险评估的心脏细胞模型的优化。
Corrigendum: Optimization of an Cardiac Cell Model for Proarrhythmia Risk Assessment.
作者信息
Dutta Sara, Chang Kelly C, Beattie Kylie A, Sheng Jiansong, Tran Phu N, Wu Wendy W, Wu Min, Strauss David G, Colatsky Thomas, Li Zhihua
机构信息
Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
Marshview Life Science Advisors, Seabrook Island, SC, United States.
出版信息
Front Physiol. 2017 Dec 6;8:1025. doi: 10.3389/fphys.2017.01025. eCollection 2017.
Abstract
[This corrects the article on p. 616 in vol. 8, PMID: 28878692.].
摘要
[这更正了第8卷第616页上的文章， PMID: 28878692。]
Zotero 插件